PayPoint (LON:PAY)‘s stock had its “overweight” rating reaffirmed by equities researchers at JPMorgan Chase & Co. in a research report issued on Wednesday, ARN reports. They currently have a GBX 1,407 ($21.47) price objective on the stock. JPMorgan Chase & Co.’s price target indicates a potential upside of 29.20% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Canaccord Genuity raised their price target on shares of PayPoint from GBX 999 ($15.25) to GBX 1,200 ($18.32) in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Numis Securities Ltd reiterated a “sell” rating on shares of PayPoint in a research note to investors on Wednesday. They now have a GBX 695 ($10.61) price target on the stock. Finally, analysts at Panmure Gordon raised their price target on shares of PayPoint from GBX 765 ($11.68) to GBX 1,000 ($15.26) in a research note to investors on Friday, May 31st. They now have a “hold” rating on the stock.
One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of GBX 1,027 ($15.67).
Shares of PayPoint (LON: PAY) opened at 1107.00 on Wednesday. PayPoint has a one year low of GBX 670.50 and a one year high of GBX 1115.00. The stock’s 50-day moving average is currently GBX 729.5. The company’s market cap is £751.4 million.
PayPoint plc is a holding company. The Company and its subsidiaries are engaged in providing clients with consumer payment transaction processing and settlement.